Stockscreener 앱 받기
525.16
1.09%
-4.26
전일 마감가:
$529.42
열려 있는:
$528.32
하루 거래량:
46,762
Relative Volume:
0.02
시가총액:
$184.23B
수익:
$8.71B
순이익/손실:
$2.48B
주가수익비율:
77.00
EPS:
6.82
순현금흐름:
$1.75B
1주 성능:
+2.88%
1개월 성능:
+4.41%
6개월 성능:
+4.56%
1년 성능:
+40.19%
1일 변동 폭
$523.00
$528.32
1주일 범위
$501.67
$535.60
52주 변동 폭
$378.87
$616.00
인튜이티브 서지컬 Stock (ISRG) Company Profile
명칭
Intuitive Surgical Inc
전화
(408) 523-2100
주소
1020 KIFER ROAD, SUNNYVALE
ISRG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
524.21 | 184.23B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
165.59 | 48.46B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
98.23 | 47.15B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
239.22 | 35.24B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
81.47 | 16.39B | 3.90B | 392.30M | 288.10M | 1.95 |
인튜이티브 서지컬 Stock (ISRG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | 재확인 | Citigroup | Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-11-17 | 개시 | HSBC Securities | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-04-19 | 재확인 | BTIG Research | Buy |
| 2023-04-19 | 재확인 | BofA Securities | Buy |
| 2023-04-19 | 재확인 | Citigroup | Buy |
| 2023-04-19 | 재확인 | Evercore ISI | In-line |
| 2023-04-19 | 재확인 | JP Morgan | Overweight |
| 2023-04-19 | 재확인 | Morgan Stanley | Equal-Weight |
| 2023-04-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2023-04-19 | 재확인 | Raymond James | Outperform |
| 2023-04-19 | 재확인 | Stifel | Buy |
| 2023-04-19 | 재확인 | Truist | Buy |
| 2023-04-19 | 재확인 | Wells Fargo | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-23 | 개시 | William Blair | Outperform |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-13 | 개시 | Mizuho | Neutral |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2022-03-25 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | 다운그레이드 | Redburn | Buy → Neutral |
| 2022-01-21 | 재확인 | BTIG Research | Buy |
| 2022-01-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-21 | 재확인 | Deutsche Bank | Hold |
| 2022-01-21 | 재확인 | Evercore ISI | In-line |
| 2022-01-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-01-21 | 재확인 | Piper Sandler | Neutral |
| 2022-01-21 | 재확인 | Raymond James | Outperform |
| 2022-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2022-01-21 | 재확인 | Stifel | Buy |
| 2022-01-21 | 재확인 | UBS | Neutral |
| 2022-01-21 | 재확인 | Wells Fargo | Overweight |
| 2022-01-10 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-07-21 | 재확인 | BofA Securities | Neutral |
| 2021-07-21 | 재확인 | Citigroup | Buy |
| 2021-07-21 | 재확인 | JP Morgan | Overweight |
| 2021-07-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-07-21 | 재확인 | Piper Sandler | Neutral |
| 2021-07-21 | 재확인 | SVB Leerink | Mkt Perform |
| 2021-07-21 | 재확인 | Stifel | Buy |
| 2021-07-21 | 재확인 | UBS | Neutral |
| 2021-07-21 | 재확인 | Wells Fargo | Overweight |
| 2021-07-14 | 재확인 | Goldman | Buy |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-04-21 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2021-04-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | 개시 | Citigroup | Buy |
| 2020-12-15 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | 개시 | Argus | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-07-20 | 재확인 | Bernstein | Outperform |
| 2020-04-28 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | 다운그레이드 | CFRA | Hold → Sell |
| 2020-04-17 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-04-01 | 다운그레이드 | Oppenheimer | Perform → Underperform |
| 2020-01-27 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-12-12 | 재확인 | Wells Fargo | Outperform |
| 2019-11-21 | 개시 | Oppenheimer | Perform |
| 2019-07-19 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-22 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-02 | 개시 | Deutsche Bank | Buy |
| 2018-10-31 | 재확인 | Piper Jaffray | Overweight |
| 2018-10-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
모두보기
인튜이티브 서지컬 주식(ISRG)의 최신 뉴스
Urology Robotics Devices Market to Reach $28.57 Billion by 2033 | CAGR 17.7% | Intuitive Surgical, MicroPort, Asensus - openPR.com
Is Intuitive Surgical (ISRG) The Best Stock to Buy and Hold For 10 Years? - Insider Monkey
12 Best Stocks to Buy and Hold For 10 Years - Insider Monkey
Prediction: 2 Stocks Will Be Worth More Than Palantir Technologies in 2026 - Yahoo Finance
Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, David Einhorn, Point72 Asset Management, Irenic Capital Management, Balyasny Asset Management, Phinia Inc (PHIN), Intuitive Surgical Inc (ISRG), and More - Insider Monkey
Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility - MedTech Dive
Healthcare Skill Training: Intuitive Surgical India Partners with HSSC - Rediff
Medtech companies try to head off price increases after tariffs - Modern Healthcare
Laparoscopic Surgical Robot Market New Product Development & - openPR.com
Intuitive Surgical Insider Sold Shares Worth $1,248,000, According to a Recent SEC Filing - marketscreener.com
Intuitive Surgical director Amy Ladd sells $4.44m in stock By Investing.com - Investing.com South Africa
Intuitive Surgical director Amy Ladd sells $4.44m in stock - Investing.com Australia
Intuitive surgical director Jami Nachtsheim sells $1.25m in stock By Investing.com - Investing.com Nigeria
Intuitive's (ISRG) da Vinci SP System Gains FDA Approval for New Surgical Procedure | ISRG Stock News - GuruFocus
Intuitive surgical director Jami Nachtsheim sells $1.25m in stock - Investing.com
Jim Cramer on Intuitive Surgical, Inc. (ISRG): ‘As Relevant As Ever’ - Insider Monkey
Intuitive Surgical (ISRG) Expands FDA Clearance for da Vinci Sys - GuruFocus
FDA Expands Intuitive Surgical (NasdaqGS:ISRG) da Vinci SP System for Advanced Colorectal Surgeries - Yahoo Finance
Intuitive’s da Vinci SP Wins FDA Nod for Transanal Local Excision/Resection - Medical Product Outsourcing
Intuitive Surgical Receives US FDA Approval for da Vinci Single Port Surgical System - marketscreener.com
Intuitive's da Vinci Single Port system granted new FDA nod (ISRG) - Seeking Alpha
Intuitive earns expanded FDA nod for da Vinci single port system - MassDevice
Intuitive Announces FDA Clearance Of Da Vinci Single Port For Transanal Local Excision/Resection - marketscreener.com
Intuitive Surgical, Inc. (ISRG): Among the Best Stocks to Buy During Recession - Insider Monkey
FDA approves new da Vinci system for colorectal surgery - Investing.com
Intuitive Announces FDA Clearance of da Vinci Single Port for Tr - GuruFocus
Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection - GlobeNewswire
Trump's Tariffs Could Impact This Top Growth Stock. Here's Why It's Still a Buy - The Motley Fool
Argus Cuts Price Target on Intuitive Surgical to $600 From $630 - marketscreener.com
Intuitive and HSSC come together to strengthen India’s healthcare workforce - Pharmabiz.com
Laparoscopic Devices Market Generated Opportunities, Future - openPR.com
Silicon Valley company's robotic technology helping fight cancer - NBC Bay Area
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - MSN
ISRG Vs. SYK: Which Robotic-Device Innovator Is A Better Buy? - Barchart.com
ISRG vs. SYK: Which Robotic-Device Innovator Is a Better Buy? - Zacks Investment Research
Medtronic submits Hugo soft tissue robot for FDA approval - MedTech Dive
How Big a Threat Is China to Intuitive Surgical Stock? - Nanalyze
Surgical robot officially revealed - Winnipeg Free Press
This Buy-Rated Robotics Stock Has An Unmatched Position - Barchart.com
Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Look at Its 11.94% Potential Upside for Investors - DirectorsTalk Interviews
Tariffs are hitting surgical robots and pacemakers, but device companies aren’t sweating it, yet - statnews.com
Intuitive Surgical, Inc. (ISRG): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential - Insider Monkey
ISRG Stock Quote Price and Forecast - CNN
Is Intuitive Surgical a Buy After Volatile Reaction to Earnings? - MSN
Med tech majors unfazed by tariffs - BioWorld MedTech
Trade Tracker: Stephanie Link buys Intuitive Surgical - CNBC
Intuitive Surgical Inc (ISRG) Trading 4.11% Higher on Apr 24 - GuruFocus
Intuitive Surgical: Decent Results But Waiting For An Entry Point (NASDAQ:ISRG) - Seeking Alpha
Intuitive Surgical Inc (ISRG) Stock Price, Trades & News - GuruFocus
What's Next For Intuitive Surgical Stock After An Upbeat Q1? - Nasdaq
Intuitive surgical projects 15%-17% procedure growth for 2025 amid strong Q1 results - MSN
인튜이티브 서지컬 (ISRG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.14%
자본화:
|
볼륨(24시간):